欧洲 · 财经报刊 · Financial Times
FDA rejects cancer drug invented in China in blow to Beijing’s biotech sector
详细摘要
Summit’s Ivonescimab was seen as a test case for whether the country’s medicine could pass scrutiny in the US
MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.ft.com)
